Good Distribution Practices in the Pharma Supply Chain - Focus on Canada
Add bookmark
In 2013 Health Canada begins its 3 year cycle of updating Guidlines for Temperature Control of Drug Products during Storage and Transportation (GUI-0069).
Canada is playing an increasingly large role in the biopharma industry, with some of the major players making significant investments in recent years.
Health Canada's latest guidelines, GUI-0069, came into force on April 28th 2011, superseding that released in October 2005. The guide discusses Health Canada's guidelines for temperature control of drug products during storage and transportation.
[eventpdf]
Much of the focus of these new guidelines is in improving monitoring, recording and supervision of existing good practice in the field of temperature controlled distribution, rather than imposing new obligations.
The additions introduced in GUI-0069 build on the good practice that has formed around the distribution of temperature controlled pharmaceuticals in recent years, in part as a result of the greater emphasis being placed on the growing biopharmaceutical and life sciences industries.
Find out more about implementing Health Canada’s revised guideline.
To view Guidelines for Temperature Control of Drug Products during Storage and Transportation (GUI-0069)
| Have Your Say Rate this feature and give us your feedback in the comments section below |
